Trevi Therapeutics, Inc. (TRVI) has a market capitalization of $1.8B and trades at $14.04. The 52-week range is 4.85-14.39.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -48.4, Earnings Per Share (EPS) of $-0.29.
The stock has a beta of 1.00, operates in the Healthcare sector.
